| 1. |
Wakisaka M, Kamouchi M, Kitazono T., Lessons from the trials for the desirable effects of sodium glucose co-transporter 2 inhibitors on diabetic cardiovascular events and renal dysfunction., Int J Mol Sci, doi: 10.3390/ijms20225668, 2019.11. |
| 2. |
Masahiro Kamouchi, Risk management for the prevention of dementia, Japan Brain Dock Society Report 2017, 67-75, 2017.12. |
| 3. |
Masahiro Kamouchi, Optimal Anticoagulation for Patients With Atrial Fibrillation - Benefits for Reducing Stroke Severity., Circ J, 2017.02. |
| 4. |
Matsuo Ryu, Masahiro Kamouchi, Timing of Anticoagulant Therapy After Acute Ischemic Stroke., Circ J, 2017.01. |
| 5. |
Kamouchi M. , Stroke features and management in patients with chronic kidney disease. , Contributions to Nephrology, 2012.12. |
| 6. |
Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Oobosh I H. , Novel therapeutic strategies targeting innate immunity after stroke. , J Neurochem, 2012.08. |
| 7. |
Kamouchi M, Ago T, Kuroda J, Kitazono T, The possible roles of brain pericytes in brain ischemia and stroke., Cellular and Molecular Neurobiology, 2012.03. |
| 8. |
Ago T, Kuroda J, Kamouchi M, Sadoshima J, Kitazono T., Pathophysiological roles of NADPH oxidase/nox family proteins in the vascular system. -Review and perspective-., Circ J , 2011.06. |
| 9. |
Kamouchi M, Ago T, Kitazono T., Brain pericytes: emerging concepts and functional roles in brain homeostasis., Cell Mol Neurobiol, 2011.03. |
